These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8108134)

  • 1. Functional identification and molecular cloning of a rat gene mediating growth inhibition and programmed cell death in normal and transformed rat cell lines.
    Schwarte-Waldhoff I; Martin W; Willecke K; Schäfer R
    Oncogene; 1994 Mar; 9(3):899-909. PubMed ID: 8108134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colony stimulating factor-1 induced growth stimulation of v-fms transformed fibroblasts.
    Lyman SD; Park L; Rohrschneider LR
    Oncogene; 1988 Oct; 3(4):391-5. PubMed ID: 2856249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
    Wang Y; Iliakis G
    Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gangliosides in human urothelial cell lines of different transformed phenotypes: the effect of v-raf-oncogene transfection.
    Ugorski M; Dus D; Skouv J; Påhlsson P; Radzikowski C
    Anticancer Res; 1989; 9(6):1583-6. PubMed ID: 2627112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of the v-myc oncogene with H-ras on radioresistance.
    McKenna WG; Weiss MC; Endlich B; Ling CC; Bakanauskas VJ; Kelsten ML; Muschel RJ
    Cancer Res; 1990 Jan; 50(1):97-102. PubMed ID: 2403420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
    Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions.
    Martin W; Zempel G; Hülser D; Willecke K
    Cancer Res; 1991 Oct; 51(19):5348-51. PubMed ID: 1913656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts.
    Hajnal A; Klemenz R; Schäfer R
    Cancer Res; 1993 Oct; 53(19):4670-5. PubMed ID: 7691400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells.
    Su ZZ; Lin J; Prewett M; Goldstein NI; Fisher PB
    Anticancer Res; 1995; 15(5B):1841-8. PubMed ID: 8572568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
    Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
    J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ha-ras-induced transformed phenotype of rat-1 cells can be suppressed in hybrids with rat embryonic fibroblasts.
    Willecke K; Griegel S; Martin W; Traub O; Schäfer R
    J Cell Biochem; 1987 May; 34(1):23-30. PubMed ID: 3495543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators.
    Tchernitsa OI; Zuber J; Sers C; Brinckmann R; Britsch SK; Adams V; Schäfer R
    Oncogene; 1999 Sep; 18(39):5448-54. PubMed ID: 10498898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
    Yam JW; Chan KW; Hsiao WL
    Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes.
    Spandidos DA; Frame M; Wilkie NM
    Anticancer Res; 1990; 10(6):1543-54. PubMed ID: 2285227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal response of oncogene-transfected rat cells.
    Li GC; Ling CC; Endlich B; Mak JY
    Cancer Res; 1990 Aug; 50(15):4515-21. PubMed ID: 2196114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
    You M; Bose HR
    Methods; 1998 Dec; 16(4):373-85. PubMed ID: 10049645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.